1. Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3‐Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?. Issue 2 (23rd December 2016) Authors: KOBAYASHI, Minoru; NUKUI, Akinori; KAMAI, Takao Journal: LUTS Issue: Volume 10:Issue 2(2018) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗